A Study of Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01).
Clinical trial NCT05953909 · UNKNOWN
Trial details
- NCT number
- NCT05953909
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-01
- Primary completion
- 2023-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.